A 'magic bullet' for polycystic kidney disease in the making

Polycystic kidney disease (PKD) is a debilitating hereditary condition in which fluid-filled sacs form and proliferate in the ...
Science Daily

New antibody breakthrough could finally slow polycystic kidney disease

A specially engineered antibody that can infiltrate kidney cysts has shown the ability to block key growth signals driving ...
ascopubs.org

Evaluation of Biologic End Points and Pharmacokinetics in Patients With Metastatic Breast Cancer After Treatment With Erlotinib, an Epidermal Growth Factor Receptor Tyrosine ...

Long-Term Cardiac Follow-Up in Relapse-Free Patients After Six Courses of Fluorouracil, Epirubicin, and Cyclophosphamide, With Either 50 or 100 mg of Epirubicin, As Adjuvant Therapy for Node-Positive ...
Targeted Oncology

Giredestrant Outperforms Standard of Care in ER+/HER2– Early Breast Cancer

Giredestrant significantly improves IDFS in ER-positive, HER2-negative early-stage breast cancer, surpassing standard ...
MedPage Today on MSN

Livers of MASLD Patients End Up Less Fatty With Novel Injectable

No drugs are specifically indicated for MASLD, but the FDA has granted accelerated approval to two drugs for non-cirrhotic ...
ascopubs.org

Tumor Variants by Hormone Receptor Expression in White Patients With Node-Negative Breast Cancer From the Surveillance, Epidemiology, and End Results Database

Adjuvant Clodronate Treatment Does Not Reduce the Frequency of Skeletal Metastases in Node-Positive Breast Cancer Patients: 5-Year Results of a Randomized Controlled Trial PURPOSE: Hormone receptor ...